:max_bytes(150000):strip_icc()/GettyImages-2153417526-fc6ade053d5b43638e1d603f627e4b42.jpg?w=1920&resize=1920,1267&ssl=1 "GSK Stock Jumps on Long-Term Outlook Boost, .5B Share Buyback Plan | Global News Avenue")
GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2153417526-fc6ade053d5b43638e1d603f627e4b42.jpg)
Key points
- GSK PLC listed shares surged Wednesday after the pharmaceutical company boosted its long-term outlook and launched a $2.5 billion stock buyback on optimism about the sales of new drugs.
- The British drug giant said it expects revenue to exceed £40 billion in 2031.
- GSK’s fourth-quarter core earnings per share and revenue also outperformed estimates.
GSK PLC (GSK) U.S.-listed stocks surged on Wednesday after pharmaceutical companies boosted their long-term outlook and launched a copy of the company. Stock buyback Behind the optimistic attitude towards new drug sales.
The UK drug manufacturer also reported estimated fourth quarter and sales growth next year.
GSK said revenue jumped to £40 billion (about $50 billion) in 2031, up from the previous prospect of £38 billion (about $47.5 billion) On “Later Pipeline Progress”.
CEO (CEO) Emma Walmsley said the company canceled its 2031 estimate as it “raises R&D investment and prioritizes R&D in respiratory, immunology and inflammation, oncology and HIV. invest.”
GSK expects revenue growth of 3%-5% in 2025
GSK also announced plans for a £2 billion ($2.5 billion) share buyback program over the next 18 months.
The company said it expects revenue to grow 3% to 5% in 2025, even as vaccine sales may drop low unit numbers. It can be seen that analysts surveyed by Alpha are looking for a 4% revenue growth.
Its 23.2p ($0.29) core Earnings per share (EPS) In the fourth quarter and £8.12 billion revenue also beat the estimates.
By midday Wednesday, GSK listed stocks rose 8%.
TradingView
:max_bytes(150000):strip_icc()/GettyImages-2153417526-fc6ade053d5b43638e1d603f627e4b42.jpg?w=1200&resize=1200,0&ssl=1&description=GSK+Stock+Jumps+on+Long-Term+Outlook+Boost%2C+%242.5B+Share+Buyback+Plan+%7C+Global+News+Avenue){kind=link}